9
-THC exerts potent effects on the immune system through CB 1 -and CB 2 -dependent and -independent mechanisms, depending on the immune stimulus (Do et al., 2004; Lu et al., 2006a, b; Rao and Kaminski, 2006; Rao et al., 2004) . Expression of CB 1 and CB 2 varies among leukocytes and can change in response to immune stimulation, albeit CB 2 expression is greater than CB 1 in cell of the immune system (Bouaboula et al., 1993; Galiègue et al., 1995; Nong et al., 2001) .
Although pharmacological effects by Δ 9 -THC have been extensively investigated on isolated immune cells in vitro, the effects of Δ 9 -THC on the immune system in vivo are more complex. Factors contributing to this complexity include the type of stimulus used, site of the immune response, the interaction between multiple cell types, and the kinetics of the cellular arms of immune response, none of which can be completely recapitulated in vitro. To date, a few studies have focused on the effects of Δ 9 -THC on multiple immune cell populations, such as in host resistance models to infection and tumor challenges (Buchweitz et al., 2007 (Buchweitz et al., , 2008 Cabral et al., 1986; Klein et al., 2000; Mishkin and Cabral, 1985; Morahan et al., 1979; Newton et al., 1994; Zhu et al., 2000) . Many of these studies show that Δ 9 -THC impairs host immune surveillance, thereby increasing adverse immune outcomes.
Our laboratory has characterized an influenza host challenge model in order to investigate the effects of Δ 9 -THC on the in vivo antiviral immune responses (Buchweitz et al., 2007 (Buchweitz et al., , 2008 . Infection with influenza virus induces a broad immune response within the airways of the lungs and associated lymph nodes, which is classically a T helper type 1 (Th 1 ) response as characterized by production of interferon-gamma (IFN-γ) by antigenspecific T cells. More recently, a role for interleukin-17 in the immunopathology of influenza infection has been identified, which is, in part, responsible for an influenza-induced neutrophilia (Crowe et al., 2009) . The heterogeneous population of dendritic cells (DC) are important in the initiation of the aforementioned T-cell immune responses (Lee and Iwasaki, 2007) . Conventional DC (cDC) present antigen to elicit effector immune cells, thereby dictating the magnitude and phenotype of the effector response (e.g., Th 1 ) (Banchereau and Steinman, 1998) . By contrast, plasmacytoid DC (pDC) primarily produce type I IFNs (Asselin-Paturel et al., 2001) . Other APC, such as alveolar macrophages (AM), are involved in phagocytosis and cytokine production (Kobzik et al., 1993) . The function of inflammatory myeloid cells, also termed inflammatory or monocytic DC or inflammatory monocytes, is less well understood but is thought to contribute to the inflammatory milieu (Drutman et al., 2012) . Also macrophages/monocytes (Mac/ MФ) are involved in cytokine production (Auffray et al., 2009) .
Recently, we demonstrated that signaling via CB 1 and CB 2 suppressed the magnitude of the immune response, at least in part, by regulating DC function. In turn, the lack of CB 1 and CB 2 exacerbated inflammation and tissue damage after influenza infection, with the greatest inflammation observed at 3 days post infection (dpi) (Karmaus et al., 2011) . Therefore, the objective of this study was to determine the effect of Δ 9 -THC on APC populations involved in the immune response to influenza at 3 dpi and to identify whether CB 1 and CB 2 are involved in modulating this anti-influenza response. Collectively, our results suggest that Δ 9 -THC suppresses DC, Mac/MФ, and inflammatory myeloid cell responses to a great extent via CB 1 and/or CB 2 , thereby impairing cellular immune responses induced by influenza infection.
MATeRIALS AND MeTHoDS
Mice. Age-matched C57Bl/6 wild type (WT) and CB 1 −/− CB 2 −/− mice bred on a C57Bl/6 background were used for in vivo experiments. WT mice were purchased from the National Cancer Institute (Frederick, MD). CB 1 −/− CB 2 −/− mice were a kind gift of Dr Andreas Zimmer from the University of Bonn (Karsak et al., 2007) . They were bred and housed at the animal care facilities at Michigan State University. All mice were given food (Purina Certified Laboratory Chow) and spring water ad libitum and were housed at 40-60% relative humidity and room temperature (21°C-24°C) with a 12-h light/dark cycle. Female mice were used for experiments between the ages of 8-12 weeks and randomly assigned to experimental groups. Female mice were used exclusively in this study primarily due to the dominant behavior exhibited by group housed male mice (i.e., fighting) and the potential confounding effects on immune competence associated with stress. Prior to experiments, mice were transferred to plastic cages containing sawdust bedding and quarantined for 1 week. Mice transgenic for T-cell receptor (Tcr) α and Tcr β (OT-1), generating CD8 + T cells specific for chicken ovalbumin ; amino acid sequence: SIINFEKL), were purchased from Jackson Laboratories (Bar Harbor, ME). All CB 1 −/− CB 2 −/− breeders, experimental WT and CB 1 −/− CB 2 −/− mice, and sentinels were subjected to rigorous veterinary exams and were found negative for pathogens tested. All animal housing, handling, and procedures were approved by and performed following the guidelines of the Institutional Animal Care and Use Committee at Michigan State University.
Virus instillation.
Mice were randomly assigned to a treatment group 1 week prior to initiation of the experiment. A nonlethal dose of 50 plaque-forming units of A/PR/8/34 (PR8) influenza, a generous gift from Dr Allen Harmsen (Montana State University, Bozeman, MT), or 0.9% saline (by weight of NaCl dissolved in water; SAL) was instilled at 25 µl per nostril per mouse under anesthesia with 4% isoflurane.
Δ
9 -THC treatment. The National Institute on Drug Abuse (NIDA, Bethesda, MD) provided Δ 9 -THC for experimental use. For in vivo experiments, mice received corn oil (CO) vehicle (VH) or Δ 9 -THC (75 mg/kg/day per mouse) by oral gavage at 0.1 ml/g body weight for five consecutive days (−2 to 2 dpi) surrounding the instillation of PR8. This dose was chosen based on historical data, and although there is low absorption through the gastrointestinal tract following this clinically relevant route of administration, serum levels of Δ 9 -THC in the mice are comparable with serum Δ 9 -THC levels in humans after smoking marijuana. Specifically, after five consecutive days of treatment by oral gavage with 75 mg/kg Δ 9 -THC, mouse serum reached concentrations of 66.2 ng/ml of Δ 9 -THC 4 h after the last Δ 9 -THC dose (Buchweitz et al., 2007 (Buchweitz et al., , 2008 , whereas human serum Δ 9 -THC concentrations have ranged between 57 and 268 ng/ml (Azorlosa et al., 1992) .
Necropsy and tissue collection. Three dpi, mice were anesthetized with 250 mg/kg pentobarbital (Fatal-Plus, Vortech, Dearborn, MI) followed by euthanasia via exsanguination of the abdominal aorta. Lung lobes were excised en bloc and either immersed in TRI Reagent (Sigma, St Louis, MO) for RNA isolation (n = 5) or stored in ice-cold RPMI and disrupted using a cell dissociation sieve kit (CD-1, Sigma) to obtain a single cell suspension (n = 5) for cytometric analysis. The experiments presented were repeated twice with similar results using n = 5/group. RNA isolation and low density microarray mouse immune panel. RNA was isolated from whole lungs using manufacturer's instructions for TRI Reagent (Sigma). RNA was converted into cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA) using 2 µg in a total reaction volume of 50 µl according to manufacturer's instructions. TaqMan assay-based mouse immune panel low density microarrays were obtained from Applied Biosystems, and reactions were set up according to manufacturer's instructions. In an 8 × 48 design, each well was loaded with 50 ng cDNA and centrifuged twice at 1100 rpm using a Sorvall Legend T (Thermo Fisher, Waltham, MA). Analysis was performed with an Applied Biosystems 7900HT Real-Time PCR System. Baseline fluorescence was set at 2-5 cycles for the internal control, 18S rRNA gene, and 2-13 cycles for target genes to determine thresholds for Ct values. Fold change was calculated by the ΔΔCt method (Livak and Schmittgen, 2001 ) compared with WT-CO-SAL, which was arbitrarily assigned a value of 1. All data were normalized with Blom transformation, and statistical analyses were performed with a factorial ANOVA 2 × 2 × 2 (genotype, immune stimulation, drug treatment) design using Statistical Analysis System (SAS) version 9.1.3 (Cary, NC). Gene expression values were log transformed, mean centered, and normalized within genes with Cluster v2.11 and visualized using Treeview v1.60 (Eisen et al., 1998) .
Restimulation of immune cell populations isolated from lungs. After mechanical disruption of lung tissue, cells were restimulated with phorbol myristate acetate (PMA; 40nM) and ionomycin (Io; 0.5µM) (both from Sigma) for 5 h in 2% bovine calf serum (BCS) RPMI and 1× Brefeldin A (Biolegend, San Diego, CA).
Surface antibody labeling for flow cytometry. All staining protocols were performed in 96-well round bottom plates (BD Falcon, Franklin Lakes, NJ). Cells isolated from the lungs were washed with FACS buffer (1× HBSS, 1% bovine serum albumin, 0.1% sodium azide, pH 7.6), and surface Fc receptors were blocked with anti-mouse CD16/CD32 (BD Biosciences, Franklin Lakes, NJ) for 15 min at 4°C. Cells were labeled for 30 min at 4°C with the following antibody clones, all from Biolegend: CD4 (clone RM4-5), CD8 (53-6.7), NK1.1 (CD161, PK136) for lymphocyte analysis, and CD11b (M1/70), CD11c (N418), CD80 (16-10A1), CD86 (GL-1), Gr-1 (RB6-8C5), major histocompatibility complex I ( −/− mice were flushed for bone marrow, and 1 × 10 6 cells were grown in 4 ml of RPMI media supplemented with 10% serum containing 100 units/ml penicillin and 100 µg/ml streptomycin (Gibco, Invitrogen) in a 6-well dish for 9 days in the presence of granulocyte-macrophage colony stimulating factor (20 ng/ml; Peprotech, Rocky Hill, NJ), with 50% of media replaced on days 3, 6, and 8. After 9 days, bone marrow-derived DC (bmDC) were left unstimulated (naive; NA) or stimulated with toll-like receptor (TLR) ligands: resiquimod (R848; 5 µg/ml) or LPS (1 µg/ml) in the presence of Δ 9 -THC (10µM) or VH (0.1% ethanol) in 2% BCS RPMI. After 24 h, bmDC were stained using the same antibodies as for the previously mentioned in vivo experiment and analyzed by flow cytometry with the same gating scheme.
Coculture of bmDC and OT-1 cells in vitro.
Splenocytes from OT-1 mice were isolated and labeled with Cell Trace (Invitrogen) proliferation dye to track loss of fluorescent staining as an indicator for proliferation. NA or TLRstimulated and Δ 9 -THC-or VH-treated bmDC were incubated with SIINFEKL for 2 h and washed thrice with RPMI before incubation with OT-1 splenocytes. Four days after coculture, cells were restimulated with SIINFEKL in the presence of Brefeldin A for 5 h in 2% fetal bovine serum RPMI. Subsequently, cells were stained with LIVE/DEAD dye (Invitrogen), fluorescent antibodies to CD8 and IFN-γ, and analyzed by flow cytometry as described previously. The gating was performed in the following order: singlets, LIVE/DEAD, and CD8 for graphs showing proliferation or proliferation and IFN-γ production.
Statistical analysis.
Graphing and statistical analyses were performed using GraphPad Prism v4.03. The mean ± SE is expressed in all bar graphs. For gene expression data, SAS version 9.1.3 and factorial ANOVA were used. To determine statistically significant changes between WT and CB 1 −/− CB 2 −/− mice, in uninfected and influenza-challenged mice, two-way ANOVA for parametric data or Kruskal-Wallis test for nonparametric data was used. Bonferroni's post hoc test was used to compare select groups of samples: SAL versus PR8 Previously, the effects of CB 1 and CB 2 deletion were assessed on the host immune response to PR8 challenge. These studies identified 3 dpi as the peak time of the pulmonary inflammatory response (Karmaus et al., 2011) . To investigate the effects of Δ 9 -THC on the anti-influenza immune response in the lungs of WT and CB 1 −/− CB 2 −/− mice, a 96-gene immune panel was employed to assess gene expression changes. 18S rRNA served as the loading control, and all samples were normalized to 18S rRNA gene expression. In SAL-treated mice, mRNA levels of very few genes were changed by Δ 9 -THC treatment alone (Fig. 1A) . In contrast, PR8 challenge induced broad changes in the steady-state mRNA levels for many genes in the 96-gene panel, which were attenuated by concomitant Δ 9 -THC treatment in WT, but not CB 1 −/− CB 2 −/− mice, suggesting CB 1 -and/ or CB 2 -dependent modulation (Fig. 1B) . In addition, mRNA levels for a few genes (Fas and Il13 in SAL group and Col4a5, Cyp7a1, and Ifnγ in the PR8 group) were upregulated in CB 1 −/− CB 2 −/− mice as a result of Δ 9 -THC treatment, suggesting the potential for CB 1 -and CB 2 -independent mechanisms of Δ 9 -THC-mediated activity (Figs. 1A and 1B ).
Δ

-THC Suppressed Influenza-Induced Cytokine Production by Effector Lymphocyte Populations
Influenza infection significantly increased the total number of cells in the BALF (Fig. 2A) . We observed statistically significant changes in total cell numbers, but due to experimental variation between mice, only trends are described in BALF subpopulations. Little effect was observed on the recruitment of eosinophils and lymphocytes (both shown at 10 4 cells/ml) into the airways, but increased numbers of neutrophils and Mac/ MФ (both shown at 10 5 cells/ml) were identified, compared with SAL-treated mice ( Fig. 2A) . The presence of inflammatory cells in the BALF, total cells in lung tissue (Figs. 2A and 2B) , and percentages of T lymphocytes and NK cells in whole-lung isolates (Fig. 3) were not affected by Δ 9 -THC. Greater BALF cellularity was observed in CB 1 −/− CB 2 −/− mice compared with WT mice and consisted mainly of neutrophils and Mac/MФ ( Fig. 2A) , but as opposed to BALF, overall cell numbers in the lung tissue did not differ between the genotypes (Fig. 2B) . The percentages of lung CD4 + , CD8 + , and NK1.1 + did not change as a result of influenza infection by 3 dpi, suggesting that recruitment of these populations to the lung had not reached its peak. By contrast, lower percentages of CD8 + cells were found in the lungs of CB 1 −/− CB 2 −/− compared with WT mice, which likely occurred due to an overall increase in recruited inflammatory cells thereby decreasing the percentage of CD8 + cells (Fig. 3) . Effector function was assessed in lymphocyte populations by measuring cytokine secretion in CD4 + , CD8 + , and NK1.1 + cells. Similar to our previous study (Karmaus et al., 2011) (Figs. 4 and 5) . Overall, these results demonstrate that Δ 9 -THC suppressed the percentages of functional effector CD4 + and NK1.1 + cells 3 dpi in a CB 1 -and/or CB 2 -dependent manner.
Reduced Presence of APC With Δ
-THC Treatment After Influenza Infection
To become functional effectors, lymphocytes depend on the presence of, and interaction with, APC. In the lung, several immune cell populations including APC are present and can be identified according to their surface expression of CD11b, CD11c, and Gr-1 (Fig. 6A) (Asselin-Paturel et al., 2001; Auffray et al., 2009; Drutman et al., 2012; Gonzalez-Juarrero et al., 2003) . For this investigation, we identified granulocytes as CD11b It is important to note that there might be some limitations and exceptions to the identification strategy using surface antigens due to the heterogeneity of myeloid cell populations (one such example is in the pDC compartment as outlined in the Discussion section).
The presence of inflammatory myeloid cells, Mac/MФ, and neutrophils was significantly increased in WT mice as a result of influenza infection (Fig. 6B) . Furthermore, greater percentages -THC (75 mg/kg) for 5 consecutive days surrounding the intranasal instillation of influenza (PR8) or saline (SAL). Lung RNA was isolated 3 dpi and converted into cDNA, and gene expression levels were analyzed using a TaqMan low density gene array. Fold change values were normalized with Blom transformation, log transformed, and mean and median were centered across genes with cluster and visualized using Treeview. Shown are genes differentially regulated by at least 1.5-fold between CO and Δ 9 -THC samples, with a value of at least p ≤ 0.1 in SAL (A) and PR8-instilled (B) groups 3 dpi. Data were analyzed using factorial ANOVA in SAS version 9.1. (Fig. 6B) . The pattern of reduced presence of inflammatory myeloid cells and Mac/ MФ is similar to the reduction of cytokine secretion in CD4 + and NK1.1 + cells after Δ
9
-THC treatment as it only occurs in WT mice infected with influenza. Thus, it is plausible that these APC populations contribute to the effect of Δ 9 -THC on effector cell populations in a CB 1 -and/or CB 2 -dependent manner.
Enhanced Maturation of APC From CB 1 −/− CB 2 −/− Mice Compared With WT Mice and the Effect of Δ
-THC on APC Maturation
The maturation markers MHC I, MHC II, and CD86 were assessed in several APC populations: cDC, pDC, inflammatory myeloid cells, AM, and Mac/MФ (Fig. 7 and summary in Table 1 −/− mice (the only exception was an increase in CD86 expression in WT mice). Taken together, these results suggest that the suppression of lymphocyte effector function by Δ 9 -THC occurs by reducing the influx of APC into the lungs, rather than suppressing the maturation of APC present in the lungs.
FIg. 2. Δ
9 -THC does not alter BALF cell counts or composition or total lung cells after influenza infection. (A) BALF was isolated by flushing lungs at 3 dpi twice with 0.9 ml SAL (n = 5). Total cell numbers were counted using a hemacytometer, then BALF was centrifuged onto slides, dried, and differential cell counts were performed after Diff-Quick staining of slides. 
Attenuation of bmDC Maturation by Δ 9 -THC In Vitro
Maturation and migration of APC are inter-related processes such that changes in maturation might affect migration. Indeed, only mature DC are able to migrate; thus it is plausible that the site of infection is enriched for mature DC as immature DC do not migrate to the site of infection (De Vries et al., 2003; Lin et al., 1998) . In light of maturation-dependent migration, Δ 9 -THC might elicit its effects on the maturation of APC prior to migration, thereby reducing the number of mature APC present in the lung after influenza infection. Thus, we examined the effect of Δ 9 -THC on maturation induced by TLR ligation of bmDC in vitro (Lutz et al., 1999) . The in vitro-generated bmDC were identified as CD11b +
CD11c
+ and are therefore similar to the DC/inflammatory myeloid phenotype (Fig. 6A) . LPS (1 µg/ ml), a TLR4 ligand, significantly induced maturation in WT and CB 1 −/− CB 2 −/− bmDC, as evidenced by MHC II, CD80, and CD86 expression (Figs. 8B and 8C ). In contrast, R848 (5 µg/ ml), a TLR 7/8 agonist, did not induce bmDC maturation to the same extent as LPS, especially regarding CD86 expression (Figs. 8B and 8C ). As previously observed (Karmaus et al., 2011) , greater maturation levels, as measured by MHC I and MHC II expression, were observed in unstimulated bmDC generated from CB 1 −/− CB 2 −/− mice compared with those obtained from WT mice. 
Impaired Elicitation of T Cells After Δ
-THC Treatment of bmDC
To determine the functional consequences of Δ 9 -THCmediated suppression of TLR-stimulated maturation of bmDC, a T-cell coculture model was used. This model system recapitulates the interaction between DC and naïve T cells, which occurs after antigen capture in the lung parenchyma by DC and subsequent migration to the lung draining lymph nodes. However, this in vitro assay bypasses any need for migration and provides an indirect measurement of DC activity as a result of interaction with T cells. Again, bmDC were CD11b + CD11c + (DC/inflammatory myeloid phenotype). Splenocytes from OT-1 mice with a transgenic T-cell receptor specific to cognate epitope OVA 257-264 (SIINFEKL) were incubated with bmDC pulsed with SIINFEKL, which is an MHC I-restricted peptide, thus eliciting only CD8 + T cells. Four days after coculture, OT-1 splenocytes were restimulated with SIINFEKL to induce IFN-γ secretion (Fig. 9) . No proliferation or IFN-γ was observed in T-cell cocultures with NA (unstimulated) WT bmDC. In contrast, bmDC from (Karmaus et al., 2011) . Δ 9 -THC (10 µM) potently suppressed proliferation and IFN-γ production following stimulation of WT bmDC with either LPS or R848. Due to the high magnitude of T-cell proliferation and IFN-γ production in response to naive bmDC from CB 1 −/− CB 2 −/− mice, neither TLR stimulation nor Δ 9 -THC had any effect on the ability of CB 1 −/− CB 2 −/− bmDC to elicit T cells. These in vitro results provide evidence for immunomodulation of DC by Δ 9 -THC, resulting in impaired lymphocyte responses in a CB 1 -and/or CB 2 -dependent manner as observed after influenza infection in vivo. The impairment of lymphocyte responses after Δ 9 -THC cotreatment during influenza infection is likely a consequence of attenuated maturation-dependent migration of DC. A comprehensive summary of results is presented in Table 1 .
DISCuSSIoN
Despite the identification of CB 1 and CB 2 , the effects of cannabinoids on the immune system in health and disease have remained elusive. It has been difficult to determine the contribution of Δ 9 -THC-induced CB 1 and CB 2 signaling in adverse immune outcomes. Furthermore, only an experimental model that induces several arms of the immune system allows for the identification of leukocyte populations sensitive to Δ 9 -THC treatment. In this study, an influenza model was used to stimulate the immune system, and the inflammatory response 3 dpi was investigated after cotreatment with the nonselective CB 1 and CB 2 partial agonist, CB 2 −/− compared with WT mice (Karmaus et al., 2011) . Even during this early response to infection, immune parameters were suppressed by Δ 9 -THC in WT mice as evidenced by reduced cytokine secretion by CD4 + T cells and NK cells, lower percentages of APC populations in the lung, and decreased expression of genes associated with the immune response to influenza. Furthermore, Δ 9 -THC reduced T-cell responses through modulation of DC function in WT mice, but not CB 1 −/− CB 2 −/− mice. Thus, although other targets for Δ 9 -THC exist, CB 1 and/or CB 2 expression on myeloid cells is important in mediating the immunomodulatory effects of Δ 9 -THC on effector cell populations such as NK cells and T cells involved in the immune response to influenza virus infection.
It was evident from the in vitro bmDC studies that direct modulation of DC by Δ 9 -THC is possible. Much of our in vivo evidence suggested that the immunomodulatory effect of Δ 9 -THC was mediated via CB 1 and/or CB 2 ; in contrast, Δ 9 -THC also suppressed maturation of bmDC generated from CB 1 −/− CB 2 −/− mice. Previous studies support that both CB 1 and CB 2 contribute to the modulation of DC function by Δ 9 -THC with the use of CB 1 -and CB 2 -specific antagonists (Do et al., 2004) and that CB 1 specifically diminishes K + outward currents through K v channels to suppress DC function (Wacnik et al., 2008) . In contrast, pertussis toxin, which blocks the Gα i subunit necessary for CB 1 and CB 2 signaling (Howlett et al., 1986; Kaminski et al., 1994) , did not completely abrogate the Δ 9 -THC-mediated suppression of IL-12p40 production in bmDC (Lu et al., 2006b) . Also, selective antagonists to either CB 1 or CB 2 did not block the suppression of IL-12p40 by Δ 9 -THC (Lu et al., 2006b) . These results suggest that although CB 1 and CB 2 are involved in Δ 9 -THC modulation of DC, it is not the exclusive or sole mechanism. In this study, Δ , but not WT, mice. Other factors aside from the maturation markers assessed on bmDC might be involved in the suppression of maturation, independent of CB 1 and CB 2 . In support of this argument, R848 did not induce maturation to the same magnitude as LPS in bmDC, yet R848-treated DC were capable of eliciting effector T cells in cocultures. Moreover, cytokine production by lymphocytes was enhanced in vivo as a result of Δ 9 -THC treatment of CB 1 −/− CB 2 −/− mice, further supporting the view that targets in addition to CB 1 and CB 2 contribute to the Δ 9 -THCmediated effects on DC.
Several APC populations were identified in the lung after influenza infection by CD11b, CD11c, and Gr-1 expression. Although these three surface markers provide a simple strategy to identify different APC subsets, some exceptions must be noted. For example, pDC (identified here as
CD11c
+ CD11b − Gr-1 + ) can exhibit reduced CD11c expression (Asselin-Paturel et al., 2001) . In fact in this report, CD11c expression is lower in pDC than cDC, but our gating strategy ignores CD11c − pDC, which are a minor population. The correct identity of lung myeloid cell populations is a highly debated topic, and interpretations of our data are confined to our described gating strategy. The greatest sensitivity to Δ 9 -THC was observed by changes in the percent of lungassociated inflammatory myeloid cells and Mac/MФ. Migration of these APC populations is regulated by several chemokines and chemokine receptors (Penna et al., 2001; Randolph et al., 2008) . From the low density microarrays conducted, Δ 9 -THC reduced steady-state mRNA levels of proinflammatory cytokines, chemokine receptors, but not chemokines. Proinflammatory cytokines are involved in the maturation of DC and their precursors and positively influence their migration to the site of infection (Randolph et al., 2008) . Thus, indirect effects of reduced tissue inflammation may be involved in the suppression of maturation and maturationinduced migration of inflammatory myeloid cells and Mac/ MФ. Taken together with the reduced percentages of APC populations in the lung, the broad changes in mRNA levels might be reflective of a reduced influx of immune cells into the lung. It has been demonstrated that DC maturation is necessary for migration (De Vries et al., 2003; Lin et al., 1998) . This would suggest that infected lungs are enriched for mature DC, but the level of expression of maturation markers on DC does not differ from uninfected lungs. Indeed, aside from minor changes of MHC II on cDC, no overt changes in the maturation status of the APC subsets were observed as a result of Δ 9 -THC treatment. In vitro, Δ 9 -THC treatment impaired the LPSinduced maturation of DC as evidenced by lower expression of CD86. Therefore, it is possible that Δ 9 -THC reduces maturation of DC as demonstrated in vitro, thereby decreasing their ability to migrate and accumulate in the lung as observed in vivo, which ultimately would result in lower numbers of mature DC after infection. Furthermore, leukocyte trafficking, to a large extent, is dependent on chemokine receptors, which are part of the GPCR family (Allen et al., 2007) . Studies on cellular migration in vitro suggest a mechanism involving CB 2 -mediated diminution of signaling through chemokine receptors (Kishimoto et al., 2003; Montecucco et al., 2008) . Alternately, it has been proposed that ligation of CB 1 and CB 2 induces apoptosis in DC, which could account for the lower percentage of DC observed in the lung (Do et al., 2004) . In this study, differences in bmDC viability in vitro using the LIVE/DEAD stain were not observed (data not shown). However, in contrast to our study, Do et al. (2004) 
used a
FIg. 8. Δ
9 -THC suppresses TLR-stimulated bmDC maturation independent of CB 1 and CB 2 . Bone marrow was used to generate bmDC in the presence of granulocyte-macrophage colony stimulating factor (20 ng/ml) for 9 days. bmDC were washed and incubated for 24 h in the presence or absence (NA) of LPS (1 µg/ml) or R848 (5 µg/ml) and cotreated with VH (0.1% ethanol) or Δ 9 -THC (10 µM). After incubation, cells were stained for CD11b, CD11c, MHC I, MHC II and CD86 was performed as previously described. (A) Cells obtained after culture were CD11b + CD11c + , indicating cDC phenotype. (B) Graphs shown are concatenated samples (n = 3). (C) ANOVA tests were performed. ** (p ≤ 0.01), difference between Δ 9 -THC and VH (ethanol); ++ (p ≤ 0.01), +++ (p ≤ 0.001), difference between NA and PR8; ## (p ≤ 0.01), difference between WT and CB 1
